Varis Dışı Üst Gastrointestinal Sistem Kanamalarına Yaklaşım

Öz

Tüm gastrointestinal kanamaların % 85 inden sorumlu olan üst Gastrointestinal Sistem GİS kanamaları, önemli klinik ve ekonomik problem teşkil ederler. Son 5 dekadda tanı ve tedavideki gelişmelere rağmen mortalite oranı aynı kalmıştır. Kliniğe GİS kanama ile başvuran hastalarda riskin belirlenmesi, tedavide endoskopinin yeri, medikal ve cerrahi tedavi endikasyonları hala tartışmalı olup, hastalara yaklaşım ile ilgili net bir ortak görüş yoktur. Bu yazının amacı üst GİS kanamalara yaklaşımın nasıl olması gerektiği konusunda güncel literatür bilgilerini derlemek oldu

Approaches To With Upper Gastrointestinal Bleeding Without Varices

Öz

Upper gastrointestinal system bleedings which account for 85% of all gastrointestinal bleedings form an important clinic and economic problem. Inspite of the improvements in the diagnostic methods and treatment modalities the mortality rate remained the same. There is not a common consensus on the risk scoring, endoscopic treatment, indications of surgical and medical treatment of a patient admitting with upper gastrointestinal bleeding. The aim of this study was to review the current literature about approaches to a patient with upper gastrointestinal bleeding

Kaynakça

1. Jiranek GC, Kozarek RAA. Cost-effective approach to the patient with peptic ulcer bleeding. Surg Clin North Am. 1996; 76:83-103.
2. ASGE Standards of Practice Committee. ASGE guideline: the role of endoscopy in acute non-variceal upper-GI hemorrhage. Gastrointest Endosc. 2004; 60(4):497- 504.
3. Terdiman JP. Update on gastrointestinal breeding. Postgrad Med, 1998; 103: 43– 64
4. Blocksom JM, Tokioka S, Sugawa C. Current therapy for nonvariceal upper gastrointestinal bleeding. Surg Endosc. 2004; 18(2):186-92.
5. Lanza, FL. A guideline for the prevention and treatment of NSAID-induced ulcers. Am J Gastroenterol. 1998; 93: 2037-2046 6. van Leerdam ME, Vreeburg EM, Rauws EA, et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol. 2003; 98(7):1494-9
6. British Society of Gastroenterology Committee. Endoscopy upper Non-variceal gastrointestinal guidelines. Gut. 2002; 51(4):iv1-6.
7. haemorrhage: 8. Kwan V, Norton ID. Endoscopic management of non-variceal upper gastrointestinal haemorrhage. ANZ J Surg. 2007;77(4):222-30.
8. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000; 356:1318-21.

9. Rockall TA, Logan RF, Devlin HB, et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996; 38:316-21.
10. Vreeburg EM, Terwee CB, Snel P, et al. Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut. 1999; 44:331-5.
11. Guidelines for good practice in and audit of gastrointestinal haemorrhage. Report of a joint working group of the British Society of Gastroenterology, the Research Unit of the Royal College of Physicians of London and the Audit Unit of the Royal College of Surgeons of England. J R Coll Physicians Lond. 1992; 26:281-9.
12. upper 13. Barkun A, Bardou M, Marshall JK. Upper Nonvariceal Consensus Conference Group. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2003; 18;139(10):843-57. GI
13. Bleeding 14. Perng CL, Lin HJ, Chen CJ, et al. Characteristics of patients with bleeding peptic endoscopy and aggressive treatment. Am J Gastroenterol. 1994; 89:1811-4.
14. Savides TJ, Jensen DM. Therapeutic endoscopy for nonvariceal gastrointestinal bleeding. Gastroenterol Clin North Am. 2000; 29: 465–487
15. Steffes CP, Sugawa C. Endoscopic management gastrointestinal bleeding. World J Surg. 1992; 16: 1025– 1033
16. Memişoğlu K. Akut üst gastrointestinal sistem kanamaları. Türkiye Klinikleri J Surg Med Sci. 2005; 1(4):1-6
17. nonvariceal 18. Spiegel BM, Vakil NB, Ofman JJ. Endoscopy for acute nonvariceal upper gastrointestinal tract hemorrhage: is sooner better? A systematic review. Arch Intern Med. 2001;11;161(11):1393-404
18. Hsu PI, Lin XZ, Chan SH, et al. Bleeding peptic ulcer—risk factors for rebleeding and sequential changes in endoscopic findings. Gut. 1994;35:746-9.
19. Huang CS, Lichtenstein DR. Nonvariceal gastrointestinal upper Gastroenterol Clin North Am. 2003; 32(4):1053-1078.
20. bleeding. 21. Choudari CP, Rajgopal C, Palmer KR. Comparison of endoscopic injection therapy versus the heater probe in major peptic ulcer haemorrhage. Gut. 1992; 33:1159-61.
21. Lin HJ, Tseng GY, Perng CL, et al. Comparison of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleeding. Gut. 1999; 44:715- 9.
22. Jensen DM, Kovacs TO, Jutabha R, et al. Randomized endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent 2002;123:407-13.
23. Brullet E, Campo R, Calvet X, et al. Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer. Gut. 1996;39:155-8.
24. Lin HJ, Wang K, Perng CL, et al. Octreotide thermocoagulation for arrest of peptic ulcer randomized, controlled trial. J Clin Gastroenterol. 1995;21:95-8. or clots.
25. Gastroenterology. and heater probe hemorrhage. A prospective, 26. Jung HK, Son HY, Jung SA, et al. Comparison of oral omeprazole and endoscopic ethanol injection therapy for prevention of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh adherent clots. Am J Gastroenterol. 2002;97:1736-40.
26. Marmo R, Rotondano G, Bianco MA, et al. Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis. Gastrointest Endosc. 2003; 57(1):62-7.
27. Bell GD, McCloy RF, Charlton JE, et al. Recommendations for standards of sedation and patient monitoring during gastrointestinal endoscopy. Gut. 1991; 32(7):823-7.
28. Bell GD. Monitoring and safety in endoscopy. Baillieres Clin Gastroenterol. 1991; 5(1):79-98.
29. Ripoll C, Bañares R, Beceiro I, et al. Comparison of transcatheter arterial embolization and surgery for treatment of bleeding peptic ulcer after endoscopic treatment failure. J Vasc Interv Radiol. 2004; 15(5):447-50
30. Defreyne L, Vanlangenhove P, De Vos M, et al. Embolization as a first approach with endoscopically unmanageable acute nonvariceal gastrointestinal hemorrhage. Radiology. 2001; 218(3):739-48.
31. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000; 343: 310–316
32. Bardou M, Youssef M, Toubouti Y, et al. Newer endoscopic therapies decrease both re-bleeding and mortality in high risk patients with acute peptic ulcer bleeding: a
33. Gastroenterology. 2003; 123:239. meta-analyses. 34. Bardou M, Toubouti Y, Benhaberou- Brun D, et al. High dose proton pump inhibition decrease both re-bleeding and mortality in high-risk patients with acute peptic ulcer bleeding. A series of meta- analyses. 123:625.
34. 35. Leontiadis GI, Sreedharan A, Dorward S, et al. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess. 2007; 11(51):1-164
35. Arabi Y, Al Knawy B, Barkun AN, et al. Pro/con debate: octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin? Crit Care. 2006; 10(4):218.
36. Kullavanuaya P, Manotaya S, Thong- Ngam D, et al. Efficacy of octreotide in the control of acute upper gastrointestinal bleeding. J Med Assoc Thai. 2001; 84(12):1714-20
37. Archimandritis A, Tsirantonaki M, Tryphonos M, et al. Ranitidine versus ranitidine plus octreotide in the treatment of
38. gastrointestinal bleeding: a prospective randomised study. Curr Med Res Opin. 2000;16(3):178-83.
39. upper 39. Lai KC, Hui WM, Wong WM, et al. Treatment of Helicobacter pylori in patients hemorrhage—a long-term randomized, controlled study. Am J Gastroenterol. 2000; 95:2225-32.
40. ulcer 40. Jaspersen D, Koerner T, Schorr W, et al. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc. 1995; 41:5-7.
41. Llach J, Elizalde JI, Guevara MC, et al. Endoscopic injection therapy in bleeding Mallory-Weiss syndrome: a randomized controlled trial. Gastrointest Endosc. 2001; 54(6):679-81
42. Kortas DY, Haas LS, Simpson WG, et al. Mallory-Weiss tear: predisposing factors and predictors of a complicated course. Am J Gastroenterol. 2001; 96(10):2863-5. Gunay K, Cabioglu N, Barbaros U, et al. Endoscopic ligation for patients with active bleeding Mallory-Weiss tears. Surg Endosc. 2001; 15(11):1305-7. Epub 2001 Sep 4.
43. Linhares MM, Filho BH, Schraibman V, et al. Dieulafoy lesion: endoscopic and surgical management. Surg Laparosc Endosc Percutan Tech. 2006; 16(1):1-3
44. Park CH, Sohn YH, Lee WS et al. The usefulness of endoscopic hemoclipping for Endoscopy 2003; 35: 388–92.
45. 46. Kwan V, Bourke MJ, Williams SJ et al. Argon plasma coagulation in the management gastrointestinal experience in 100 consecutive patients with long-term follow-up. Am. J. Gastroenterol. 2006; 101: 58–63.
46. lesions: 47. Pavey DA, Craig PI. Endoscopic therapy for Gastrointest Endosc. 2004; 59(2):233-8. ectasias.